Moleculin Biotech, Inc. (MBRX)

NASDAQ: MBRX · IEX Real-Time Price · USD

3.550

+0.130 (3.80%)

At close: Jul 26, 2024, 2:17 PM

3.510

-0.040 (-1.13%)

After-hours: Jul 26, 2024, 5:23 PM EDT

Moleculin Biotech Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2015
Selling, General & Admin	9.77	10.02	11.54	8.39	6.79	6.31	Upgrade
Research & Development	18.05	19.49	18.97	14.42	12.76	11.01	Upgrade
Depreciation & Amortization	0.13	0.13	0.13	0.16	0.2	0.2	Upgrade
Operating Expenses	27.95	29.63	30.64	22.97	19.74	17.52	Upgrade
Operating Income	-27.95	-29.63	-30.64	-22.97	-19.74	-17.52	Upgrade
Interest & Investment Income	1.22	1.37	0.24	0.31	0.01	0.01	Upgrade
Other Non Operating Income (Expenses)	-0.09	-1.51	1.38	6.77	2.37	4.08	Upgrade
EBT Excluding Unusual Items	-26.82	-29.77	-29.03	-15.89	-17.36	-13.43	Upgrade
Pretax Income	-26.82	-29.77	-29.03	-15.89	-17.36	-13.43	Upgrade
Income Tax Expense	-	-	-	-	-	-0.23	Upgrade
Net Income	-26.82	-29.77	-29.03	-15.89	-17.36	-13.21	Upgrade
Net Income to Common	-26.82	-29.77	-29.03	-15.89	-17.36	-13.21	Upgrade
Shares Outstanding (Basic)	2	2	2	2	1	0	Upgrade
Shares Outstanding (Diluted)	2	2	2	2	1	0	Upgrade
Shares Change (YoY)	10.64%	3.60%	6.43%	172.97%	45.07%	57.20%	Upgrade
EPS (Basic)	-12.69	-15.07	-15.22	-8.87	-26.44	-29.18	Upgrade
EPS (Diluted)	-12.69	-15.07	-15.22	-8.87	-26.44	-29.18	Upgrade
Free Cash Flow	-24.93	-24.23	-27.71	-18.97	-18.15	-17.25	Upgrade
Free Cash Flow Per Share	-11.80	-12.26	-14.53	-10.59	-27.65	-38.12	Upgrade
EBITDA	-27.83	-29.5	-30.51	-22.8	-19.54	-17.33	Upgrade
D&A For EBITDA	0.13	0.13	0.13	0.16	0.2	0.2	Upgrade
EBIT	-27.95	-29.63	-30.64	-22.97	-19.74	-17.52	Upgrade

Source: S&P Capital IQ. Standard template.